* 1. Please select your designation(s):

* 2. Please indicate your specialties:

* 3. Please select the categories you most identify with:

* 4. Wednesday, June 25, 5:30-6:15 pm
Cutting Gordian Knots with the Shears of Genomics: A Quarter Century and Counting - Daniel Kastner, MD, PhD

  Disagree Undecided Agree Did not Attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 5. Please rate the quality of this presentation.

* 6. Did you perceive bias in this presentation?

* 7. Thursday, June 26, 8:00-9:30 am
Robert A. Good Memorial Plenary Session: Microbe-Immune Interaction in Disease

  Disagree Undecided Agree Did not attend
I will make changes in my practice as a result of what I learned in this session.

* 8. After participating in this session, are you able to:

  Yes No
Discuss the host and microbial mechanisms that synergize to cause/promote intestinal inflammation.
Describe current knowledge about the pathogenesis of atoptic dermatitis.
Discuss the role of Staphylococcus aureus in atopic dermatitis.
Elucidate the role of Staph delta toxin in allergic skin disease.
Discuss how Staph colonization may contribute to atopic dermatitis.

* 9. Please rate the quality of the presentations:

  Excellent Good Average Poor
Host-Microbial Interactions that Drive Intestinal Inflammation - Thaddeus Stappenbeck, MD, PhD
Pathogen Colonization and Allergic Skin Disease - Gabriel Nunez, MD
Immunomodulatory Molecules from the Microbiome - Dennis Kasper, MD

* 10. Did you perceive bias in any of the session presentations?

  Yes No
Host-Microbial Interactions that Drive Inestinal Inflammation - Thaddeus Stappenbeck, MD, PhD
Pathogen Colonization and Allergic Skin Disease - Gabriel Nunez, MD
Immunomodulatory Molecules from the Microbiome - Dennis Kasper, MD

* 11. Thursday, June 26, 10:00-11:30 am
Plenary Session: Epigenetic Control of Immune Responses

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 12. After participating in this session, are you able to:

  Yes No
Discuss the effects of fine-mapped, noncoding genetic variants associated with human autoimmunity on immune cell-specific enhancers.

* 13. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Control of Gene Expression by Histone Mimics - Alexander Tarakhovsky, MD, PhD
Using Dynamic Epigenetic Modifications to Analyze Transcriptional Networks Regulating Lymphocyte Activation - Harinder Singh, PhD
Genetic and Epigenetic Fine-Mapping of Causal Variants in Autoimmune Disease - Alex Marson, MD, PhD

* 14. Did you perceive bias in any of the session presentations?

  Yes No
Control of Gene Expression by Histone Mimics - Alexander Tarakhovsky, MD, PhD
Using Dynamic Epigenetic Modifications to Analyze Transcriptional Networks Regulating Lymphocyte Activation - Harinder Singh, PhD
Genetic and Epigenetic Fine-Mapping of Causal Variants in Autoimmune Disease - Alex Marson, MD, PhD

* 15. Thursday, June 26, 1:00-2:45 pm
Concurrent Thematic Symposium: Humanized Mice for Studying Immune Disorders

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 16. After participating in this session, are you able to:

  Yes No
Discuss humanized mice models.
Describe the various models of establishing human immune systems in immunodeficient mice.
Discuss barriers to creating an individualized human immune system in mice.
Describe methods of overcoming barriers to creating individualized human immune system in mice.

* 17. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Humanized Mice in Immunity, Development and Disease - Richard Flavell, PhD
Humanized Mice for the Study of Human Immunity - Dale Greiner, PhD
Personalized Immune Mice - Megan Sykes, MD

* 18. Did you perceive bias in any of the session presentations?

  Yes No
Humanized Mice in Immunity, Development and Disease - Richard Flavell, PhD
Humanized Mice for the Study of Human Immunity - Dale Greiner, PhD
Personalized Immune Mice - Megan Sykes, MD

* 19. Thursday, June 26, 1:00-2:45 pm
Concurrent Thematic Symposium: Manipulating DCs for Tolerance or Rejection

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 20. After participating in this session, are you able to:

  Yes No
Discuss current treatments for autoimmune diseases.
Describe why antigen-specific immunotherapy is the holy grail for immunotherapy of autoimmune diseases.
Discuss how dendritic cells are composed of functionally different subsets.
Describe how Follicular helper T cells are controlled by different subsets which differentially activate T cells.
Describe how the interplay between these different cell types will result in better design of the next-generation vaccines.

* 21. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Antigen-Specific Immunotherapy for Multiple Sclerosis - David Wraith, PhD
Improving Vaccines by Harnessing Dendritic Cell Subsets and T Cell Subsets - Jacques Banchereau, PhD

* 22. Did you perceive bias in any of the session presentations?

  Yes No
Antigen-Specific Immunotherapy for Multiple Sclerosis - David Wraith, PhD
Improving Vaccines by Harnessing Dendritic Cell Subsets and T Cell Subsets - Jacques Banchereau, PhD

* 23. Thursday, June 26, 1:00-2:45 pm
Concurrent Thematic Symposium: The Ups and Downs of IL-2

  Disagree Undecided Agree Did not attend
I will make changes to my practice/profession as a result of what I learned in this session.

* 24. After participating in this session, are you able to:

  Yes No
Discuss the effects of IL-2 treatment on Treg stability.
Describe the additional effects of IL-2 on innate lymphoid cells.
Discuss the role of interleukin-2 (IL-2) in immune tolerance and in stimulating effector lymphocytes, eosinophilia and unwanted immunity.
Discuss approaches to harness the potential of IL-2 for selective immunotherapy aimed at restoring immune tolerance mechanisms in inflammation, autoimmunity and graft rejection.
Describe another type of IL-2 immunotherapy targeted at stimulation of effector lymphocytes against metastatic cancer.

* 25. Please rate the quality of the session presentations:

  Excellent Good Average Poor
Immunoregulation Without Immunosuppression: The Promise of Low Dose IL-2 - David Klatzmann, MD, PhD
Effects of IL-2 Therapy on Treg Stability and Other Immune Cell Types - Jeff Bluestone, PhD
Selective Immunotherapy Using Interleukin-2 Formations - Onur Boyman, MD

* 26. Did you perceive bias in any of the session presentations?

  Yes No
Immunoregulation Without Immunosuppression: The Promise of Low Dose IL-2 - David Klatzmann, MD, PhD
Effects of IL-2 Therapy on Treg Stability and Other Immune Cell Types - Jeff Bluestone, PhD
Selective Immunotherapy Using Interleukin-2 Formations - Onur Boyman, MD

* 27. Thursday, June 26, 3:15-5:15 pm
Principles of Flow Cytometry for Immune Monitoring Course: RNA Detection by Flow Cytometry

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 28. After participating in this session, are you able to:

  Yes No
Describe the methods enabling RNA detection by flow cytometry.
Discuss the universal method for RNA preservation in fixed and permeabilized cells.
Describe DNA-based co-detection of RNA and proteins by flow cytometry.
Describe the association between telomeres and the proliferative capacity of T cells.
Discuss how telomerase maintains telomere length.
Describe how telemere length can be measured in leukoicytes by multicolor flow cytometry.

* 29. Please rate the quality of the session presentations:

  Excellent Good Average Poor
RNA Based Single-Cell Mapping of Hematopoiesis - Yury Goltsev, PhD
The Regulation of Telomere Erosion in Memory T Cells After Immune Challenge in vivo - Arne Akbar, PhD

* 30. Did you perceive bias in any of the session presentations?

  Yes No
RNA Based Single-Cell Mapping of Hematopoiesis - Yury Goltsev, PhD
The Regulation of Telomere Erosion in Memory T Cells After Immune Challenge in vivo - Arne Akbar, PhD

* 31. Thursday, June 26, 5:30-6:15 pm
Keynote Address: Immune Memory to Viruses - Rafi Ahmed, PhD

  Disagree Undecided Agree Did not attend
I will make changes in my practice/profession as a result of what I learned in this session.

* 32. Please rate the quality of this presentation.

* 33. Did you perceive bias in this presentation?

* 34. If you would like to receive a CME certificate or certificate of attendance, please indicate below.

T